Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies
Safety and Efficacy of Pregabalin in Children Aged 1 mo to 16 years with Seizures
Full IRB Study Title:
A 12-month Open-label Study To Evaluate The Safety And Tolerability Of Pregabalin As Adjunctive Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-clonic Seizures
IRB Study ID: 111109
For complete information, please view the study on clinicaltrials.gov
Lead Investigator
Michael Kohrman, MD
Director, Pediatric Neurology; Pediatric Neurologist
Pediatric Epilepsy ProgramTuberous Sclerosis ClinicNeuroDevelopmental Science Center
